BCLAF1 and hepatocellular carcinoma: Samples from the TA-sensitive group (#1–4) exhibited lower BCLAF1, HIF1α, and PD-L1 expression, while the expression of these proteins was higher in sample 5 HCC with bone metastasis after T + A treatment), as assessed by IHC staining.